Laminate Medical Technologies
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
411 Lafayette St Ste 628, New York, New ...Phone Number
(646) 722-7346Website
www.laminatemedical.comRevenue
$10.8 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Laminate Medical Technologies
Laminate Medical is dedicated to enhancing the function of arteriovenous fistulas (AVF) for hemodialysis patients worldwide. Their primary product, the VasQ extravascular support device, aims to improve surgical outcomes by providing permanent reinforcement at the anastomosis, which helps stabilize the fistula and reduce turbulent flow. The company targets healthcare providers and professionals involved in the treatment of hemodialysis patients. Laminate Medical is focused on delivering innovative solutions that promote the longevity and health of AVFs.Explore more
Laminate Medical Technologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Laminate Medical Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Laminate Medical Technologies has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Laminate Medical Technologies recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Laminate Medical Technologies
Funding: Get notified immidiatlly once Laminate Medical Technologies has new funding data
Website visits: Recent activity has been detected on your website
Laminate Medical Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Laminate Medical Technologies is spiking on competitors!
Click to see if Laminate Medical Technologies had a recent Job posting/layoffs
Product Launch: Get notified when Laminate Medical Technologies launches new products
Recommended Actions
Find VP level buyers at Laminate Medical Technologies
Find more new buyers
Compare Similar Companies to Laminate Medical Technologies
Compare insights from companies similar to Laminate Medical Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
-
2007
JB
Jeannette BakkenNetwork Administrator & Clinical Database Programmer & Contractor
Company Profile Activity
Activity Insights
Laminate Medical Technologies is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Laminate Medical Technologies is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Laminate Medical Technologies.
Laminate Medical Technologies financials insights
Gather financial insights about Laminate Medical Technologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series B
$8M
2019
Series A
$8M
Laminate Medical Technologies Tech Stack
A closer look at the technologies used by Laminate Medical Technologies
See more technologies
Laminate Medical Technologies News & Media
VasQ™ External Support Awarded Breakthrough Device Designation by the FDA
TEL AVIV, Israel--(BUSINESS WIRE)--The FDA has designated Laminate Medical’s VasQ™ External Support for the creation of arteriovenous fistulas (AVF) in hemodialysis patients as a Breakthrough Device. The FDA Breakthrough Device Program is intended to provide patients and doctors timely access to medical devices that are more effective than the current standard of care for life-threatening or irreversibly debilitating diseases or conditions. The designation is also considered by the Centers forEnrollment of the VasQ™ External Support US Pivotal Study Now Complete
TEL AVIV, Israel, Feb. 4, 2020 /PRNewswire/ -- Laminate Medical Technologies (Laminate) has announced the completion of enrollment into the VasQ™ External Support US Pivotal Study. The study was conducted at 17 sites across the U.S. and prospectively enrolled 144 male and female patients...Enrollment of the VasQ™ External Support US Pivotal Study Now Complete
Laminate Medical Technologies (Laminate) has announced the completion of enrollment into the VasQ™ External Support US Pivotal Study. The study was conducted at 17 sites across the U.S. and prospectively enrolled 144 male and female patients in need of an arteriovenous fistula (AVF) for hemodialysis. Both brachiocephalic and radiocephalic AVF patients were included in the study. The patients will be followed for two years with the primary endpoint of primary patency analyzed at six months.Enrollment of the VasQ™ External Support US Pivotal Study Now Complete
TEL AVIV, Israel--(BUSINESS WIRE)--Laminate Medical Technologies (Laminate) has announced the completion of enrollment into the VasQ™ External Support US Pivotal Study. The study was conducted at 17 sites across the U.S. and prospectively enrolled 144 male and female patients in need of an arteriovenous fistula (AVF) for hemodialysis. Both brachiocephalic and radiocephalic AVF patients were included in the study. The patients will be followed for two years with the primary endpoint of primary p
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Laminate Medical Technologies
Sign Up For FreeTo access detailed company insights
Laminate Medical is dedicated to enhancing the function of arteriovenous fistulas (AVF) for hemodialysis patients worldwide. Their primary product, the VasQ extravascular support device, aims to improve surgical outcomes by providing permanent reinforcement at the anastomosis, which helps stabilize the fistula and reduce turbulent flow. The company... Read More
